Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
54°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
InvestorkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Taps Thermo Fisher for Phase 3 and Commercial Production of CYB003
May 15, 2025
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CYBN
InvestorkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Engages Veloxity Labs for IND-Enabling Study of PTSD Drug SPC-15
May 15, 2025
Via
Investor Brand Network
Exposures
Product Safety
Tickers
SILO
Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug
May 15, 2025
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
BHVN
Is It Time to Buy the Dip in Novo Nordisk Stock?
May 15, 2025
Via
MarketBeat
Topics
Government
Exposures
Political
Product Safety
Tickers
CVS
LLY
NVO
SEPN
Cingulate Retail Buzz Rises After FDA Greenlights Summer NDA Filing For ADHD Drug
May 15, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
CING
Silo Pharma Retail Buzz Surges On FDA Toxicology Study Plans For PTSD Treatment
May 14, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
SILO
Incannex Surges 720% On Sleep Apnea Trial Progress: ‘Penny Bio Pharma Mania’ Lifts Retail Sentiment
May 14, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
IXHL
C3G & Bacopa Monnieri Gut-Brain Axis Supplement for Mental Acuity Launched
May 14, 2025
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
TFX Q1 Earnings Call: Guidance Cut and Strategic Shifts Dominate Amid Tariff Headwinds
May 14, 2025
Via
StockStory
Topics
Economy
World Trade
Exposures
Product Safety
Supply Chain
Tariff
Tickers
TFX
PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE’s Strategic Kadima Agreement
May 14, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
NRXP
FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
May 14, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
ABBV
RHHBY
FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors
May 14, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
MRK
AbbVie Gets FDA Nod For Drug To Treat Lung Cancer: Retail’s Yet To React
May 14, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
ABBV
UNH
VOO
VTI
TNDM Q1 Earnings Call: Product Expansion and Channel Initiatives Drive Growth Against Margin Pressures
May 14, 2025
Via
StockStory
Exposures
Product Safety
Tickers
TNDM
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral as Measles and MPox Resurge Globally
May 14, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
Tickers
NNVC
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances PTSD Treatment with FDA-Requested Safety Study for SPC-15
May 14, 2025
Via
Investor Brand Network
Exposures
Product Safety
Tickers
SILO
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations
May 14, 2025
Via
Investor Brand Network
Exposures
Product Safety
Tickers
TNXP
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update
May 14, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
BEAT
BMWYY
Ford Recalls Nearly 274,000 SUVs In US: Retail Gets More Bearish
May 14, 2025
Via
Stocktwits
Topics
Artificial Intelligence
Product Recall
Exposures
Artificial Intelligence
Legal
Product Safety
Tickers
F
NVDA
SCHD
VTI
Ford Issues Recall Of Over 270,000 Vehicles As Safety Concerns Mount
May 14, 2025
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
DRIV
F
GM
IYK
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
May 14, 2025
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Product Safety
Tickers
KRYS
LNTH
SRPT
WFC
Waymo Recalls Over 1,200 Robotaxis Over Software Issue: Retail Sentiment Dips On Parent Alphabet
May 14, 2025
Via
Stocktwits
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
GOOG
GOOGL
UAL
VTI
TD Securities Financial Advisor Isabella Gravinese
May 14, 2025
Via
Binary News Network
Topics
Artificial Intelligence
Economy
Retirement
Exposures
Artificial Intelligence
Interest Rates
Pension
Robert Kennedy Jr. Cheers FDA Plan To Ban Fluoride Supplements For Children, Calls Move 'Long Overdue'
May 14, 2025
Via
Benzinga
Exposures
Product Safety
Club Cruise™ Reports: Southwest Airlines Ends Open Seating, Adds Bag Fees in Major 2025 Shift
May 14, 2025
Via
24-7 Press Release
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
LUV
Telepathic iPhone? Apple Steps Into Elon Musk's Neuralink Territory With Bold Brain-Control Tech
May 14, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
AAPL
VTI
XLK
Discover the Future of Non-Invasive Body Sculpting at Scottsdale Med Spa
May 13, 2025
Via
AB Newswire
Exposures
Product Safety
Braden Counseling Center Unveils Deep TMS Therapy in Sycamore, IL
May 13, 2025
Via
Press Advantage
Exposures
Product Safety
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thiner, Less Problematic Than Warfrain: Cadrenal Therapeutics, Inc. (Nasdaq: CVKD)
May 13, 2025
Via
Get News
Topics
Death
Economy
Exposures
Death
Product Safety
Supply Chain
Tickers
ABT
CVKD
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
May 13, 2025
Via
PRLog
Topics
Death
Economy
Exposures
Death
Product Safety
Supply Chain
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.